MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades.

Liu S, Chen J, Cai X, Wu J, Chen X, Wu YT, Sun L, Chen ZJ. · 2013

Read MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. by Liu S, Chen J, Cai X, Wu J, Chen X, Wu YT, Sun L, Chen ZJ. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3743401.txt.

Description

Siqi Liu and co-authors reported a study in eLife in 2013 on how the protein MAVS switches on antiviral defenses. When RNA viruses infect a cell, sensors pass the alarm to MAVS, a protein on mitochondria that clumps into large polymers. Those polymers switch on two kinases that in turn activate the factors NF-kB and IRF3, driving production of interferons.

The team found that MAVS polymers recruit several TRAF proteins, TRAF2, TRAF5, and TRAF6, through separate binding spots. Breaking those spots, or removing the TRAF proteins, shut down IRF3 activation. The TRAFs also drove tagging reactions that pulled another protein, NEMO, into the MAVS complex, which was needed to switch on both kinases. The work maps a core step of antiviral signaling.

Catalog record

CREATORLiu S, Chen J, Cai X, Wu J, Chen X, Wu YT, Sun L, Chen ZJ.
YEAR2013
COLLECTIONPAPERS
FORMATTXT
FILE SIZE79 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3743401

Browse the full library · About the Tower of Babel